Quintiles Transnational Holdings Inc (Q.N)

Q.N on New York Stock Exchange

24 Oct 2014
Price Change (% chg)

$0.57 (+1.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for Q.N


Quintiles Transnational Holdings Inc., is a provider of biopharmaceutical development services and commercial outsourcing services. The Company operates in two segments: Product Development and Integrated Healthcare Services. The Company’s Product Development segment operates as a contract research organization (CRO) focused... (more)


Beta: --
Market Cap (Mil.): $7,326.06
Shares Outstanding (Mil.): 127.28
Dividend: --
Yield (%): --


  Q.N Industry Sector
P/E (TTM): 24.26 161.00 34.06
EPS (TTM): 2.37 -- --
ROI: 20.20 -1.64 17.45
ROE: -- -6.68 18.26
Search Stocks

UPDATE 2-Product development unit woes overshadow Quintiles profit beat

* Co raises 2014 service revenue, adjusted EPS forecast (Adds details from conference call, analysts' comments and share movement)

31 Jul 2014

REFILE-Quintiles profit more than doubles on higher services revenue growth

July 31 - Quintiles Transnational Holdings Inc , the world's largest medical contract research provider, said its quarterly profit more than doubled, helped by higher growth in its integrated healthcare services segment.

31 Jul 2014

BRIEF-Basilea Pharmaceutica - enters into agreement with Quintiles for commercialization of Zevtera/Mabelio in Europe

July 21 - Basilea Pharmaceutica AG : * Says entered into agreement with Quintiles for commercialization of

21 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.
Provider: Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks